TOBY

TOBY

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://toby.health

Last Round

VC Round

Aug 20, 2025

Total Funding Raised

$815,000

Momentum Score

25 /100

Company Overview

TOBY is a biotechnology company that is developing a noninvasive urine test for early cancer detection using spectroscopy and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

early cancer detectionmulti-cancer screeningliquid biopsynon-invasive diagnosticsurine testvolatile organic compoundsVOCsAI diagnosticsMCEDvolatolomicsspectroscopydiagnostic platformcancer risk scoremolecular diagnosticsbladder cancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TOBY Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TOBY Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 20, 2025
SeedJul 15, 2025
AcceleratorJul 15, 2025
AcceleratorJun 23, 2025

Key People

Founding team and executive leadership

Matthew Laskowski

Chief Executive Officer

Executive Team

TOBY Investors

Notable investors and investment history

InvestorRounds
Nashville Entrepreneur CenterAccelerator, Seed
LifeX VenturesAccelerator, Seed
Arizona State UniversityAccelerator
MassChallengeAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    Dan Collins appointed as an Advisor to the Board of Directors.

  • Sep 2, 2025

    Matthew Collier appointed as an independent director.

TOBY Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TOBY Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TOBY's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range10
Year Founded2023
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.